Spiriva Handihaler is intended as a once-daily maintenance treatment for COPD and should not be used for relief of acute symptoms, i.e., as rescue therapy for the treatment of acute episodes of ...

After assembly, the Spiriva Respimat inhaler should be discarded at least 3 months after first use or when the locking mechanism is engaged, whichever comes first. COPD: 2 inh of Spiriva Respimat ...

Check this table to make sure you can use your COPD inhalers together Medically reviewed by Sanja Jelic, MD Most people with ...

Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

Currently, Spiriva (tiotropium bromide ... AstraZeneca), which are ICS–LABA combinations, are other popular COPD drugs. A major limitation with the current corticosteroid therapy is that ...

Conclusion: Tiotropium appears to be at least as effective as currently available alternatives in the treatment of patients with COPD who require daily bronchodilator treatment. Its simplified ...

in moderate-to-severe COPD. In the study Spiolto - which combines tiotropium, the active ingredient in Boehringer's LAMA drug Spiriva with LABA olodaterol - demonstrated a 42 percent improved in a ...

Some patients with exacerbations of chronic obstructive pulmonary disease exhibit clear contraindications to noninvasive positive-pressure ventilation (NPPV); such contraindications include ...